NCT04628988View on ClinicalTrials.gov

A Study of CC-90011 and Comparators in Participants With Prostate Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

July 28, 2021

Primary Completion Date

May 26, 2023

Study Completion Date

May 26, 2023

Conditions

Prostatic Neoplasms

Interventions

DRUG

CC-90011

Capsule

DRUG

Abiraterone

Tablet

DRUG

Prednisone

Tablet

Trial Locations (1)

10021

Local Institution - 101, New York

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Celgene

INDUSTRY